Nova Eye Medical (EYE) Discussion, page-594

The sellers definitely appear to be out of ammo. Slow and steady buying back to 30c and beyond is ideal, fast moves are never great for a sustained rally. Rest of the small cap market is taking a beating so the fact we are doing so well is a great sign of how undervalued this is imo

As we get higher I suspect we will appear on the radars of more and more institutions/funds (the fireside chat mid-June will be very helpful as well for this) which should help push us higher and higher towards my short term target of $1 per share, which I believe is a realistic valuation based on the current fundamentals (which includes a recently FDA approved best in class recurring revenue producing device + a more speculative but higher potential project undergoing clinical trials, both of which have high growth and very large + lucrative addressable markets)